- All
- Product Development
- Clinical Development
- Business Development
- Strategy & Commercialization
- Valuations
- Regulatory Affairs
- Opportunity Mapping
- Research & IP evaluation
- Technology Transfer
- Business Strategy
- Cell Therapy
- Clinical Development Strategy
- Due Diligence
- Fibrosis
- Interim Chief Medical Officer
- Microbiome
- New Product Planning
- Oncology
- Partnering
- Partnering & deal-making
- Pharma Licensing
- Preclinical Development
Nigel Burns, PhD, LLB
Nigel is a senior biopharmaceutical executive who provides advice on strategic R&D issues for biotechnology companies, venture capital funds and governments. He also leads Alacrita's expert witness practice.